Gene · 7357
Papers2,116
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,116
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-alcoholic fatty liver disease in women - Current knowledge and emerging concepts. | JHEP Rep | 2023 | 37771547 | PubTator, text mining | PubMed |
| Emerging Tick-Borne Dabie bandavirus: Virology, Epidemiology, and Prevention. | Microorganisms | 2023 | 37764153 | PubTator, text mining | PubMed |
| SARS-CoV-2 Syncytium under the Radar: Molecular Insights of the Spike-Induced Syncytia and Potential Strategies to Limit SARS-CoV-2 Replication. | J Clin Med | 2023 | 37763019 | PubTator, text mining | PubMed |
| Natural Products and Small Molecules Targeting Cellular Ceramide Metabolism to Enhance Apoptosis in Cancer Cells. | Cancers (Basel) | 2023 | 37760612 | PubTator, text mining | PubMed |
| Inborn Errors of Metabolism with Ataxia: Current and Future Treatment Options. | Cells | 2023 | 37759536 | PubTator, text mining | PubMed |
| Toll-like receptors: their roles in pathomechanisms of atopic dermatitis. | Front Immunol | 2023 | 37731494 | PubTator, text mining | PubMed |
| Alteration in gut mycobiota of patients with polycystic ovary syndrome. | Microbiol Spectr | 2023 | 37702484 | PubTator, text mining | PubMed |
| Analysis of circulating ceramides and hexosylceramides in patients with coronary artery disease and type II diabetes mellitus. | BMC Cardiovasc Disord | 2023 | 37700226 | PubTator, text mining | PubMed |
| Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer. | Front Immunol | 2023 | 37671167 | PubTator, text mining | PubMed |
| Biology of GD2 ganglioside: implications for cancer immunotherapy. | Front Pharmacol | 2023 | 37670947 | PubTator, text mining | PubMed |
Long-term administration of intravenous Trappsol® Cyclo™ (HP-β-CD) results in clinical benefits and stabilization or slowing of disease progression in patients with Niemann-Pick disease type C1: Results of an international 48-week Phase I/II trial. | Mol Genet Metab Rep | 2023 | 37670901 | PubTator, text mining | PubMed |
| UGCG modulates heart hypertrophy through B4GalT5-mediated mitochondrial oxidative stress and the ERK signaling pathway. | Cell Mol Biol Lett | 2023 | 37658291 | PubTator, text mining | PubMed |
| Exploration of glycosyltransferases mutation status in cervical cancer reveals PARP14 as a potential prognostic marker. | Glycoconj J | 2023 | 37650946 | PubTator, text mining | PubMed |
| Genetic Testing for GBA and LRRK2 Mutations: Is it Time for Routine Use? | Mov Disord Clin Pract | 2023 | 37637988 | PubTator, text mining | PubMed |
| Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy. | Pharmaceutics | 2023 | 37631265 | PubTator, text mining | PubMed |
| Decoding Neurodegeneration: A Comprehensive Review of Molecular Mechanisms, Genetic Influences, and Therapeutic Innovations. | Int J Mol Sci | 2023 | 37629187 | PubTator, text mining | PubMed |
| Gaining New Insights into Fundamental Biological Pathways by Bacterial Toxin-Based Genetic Screens. | Bioengineering (Basel) | 2023 | 37627769 | PubTator, text mining | PubMed |
| Therapeutic Role of Pharmacological Chaperones in Lysosomal Storage Disorders: A Review of the Evidence and Informed Approach to Reclassification. | Biomolecules | 2023 | 37627292 | PubTator, text mining | PubMed |
| Peroxisome disruption alters lipid metabolism and potentiates antitumor response with MAPK-targeted therapy in melanoma. | J Clin Invest | 2023 | 37616051 | PubTator, text mining | PubMed |
| Cardiovascular Involvement in Fabry's Disease: New Advances in Diagnostic Strategies, Outcome Prediction and Management. | Card Fail Rev | 2023 | 37602190 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7357/papers?page=8